Studies Needed to Help Identify SUDEP Patient Risks
Epilepsy is a condition that affects millions of people worldwide. Sudden unexpected death in epilepsy (SUDEP) is responsible for approximately 18 percent of epilepsy-related deaths. While many different factors are...
Researchers Develop New Tool That Investigates Epilepsy Patients with Down’s Syndrome, Alzheimer’s
Research is showing that an extra chromosome called 21 is responsible for epilepsy patients developing Down’s syndrome and Alzheimer’s Disease. People generally have 23 pairs of chromosomes in their cell...
Canada Authorizes new Epilepsy Treatment
According to recent reports, Health Canada has authorized Eisai Limited’s drug FYCOMPA (perampanel) for use as a treatment option for partial-onset seizures in adults who are having difficulties with other...
Teresa Heinz Kerry Apparently Suffered Grand Mal Seizure
Reports are stating that Teresa Heinz Kerry’s recent emergency room visit was caused by a grand mal seizure. She was listed as in critical condition on Sunday, July 7. The...
Study Suggests Topamax XR has Favorable Pharmacokinetics Profile
According to information from a new study, an extended-release version of the anti-seizure drug Topamax, is showing good signs of being able to tolerate pharmacokinetics. This data was collected from...